These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3111982)
1. Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression. Kaye PM Immunology; 1987 Jul; 61(3):345-9. PubMed ID: 3111982 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin. Reiner NE; Finke JH J Immunol; 1983 Sep; 131(3):1487-91. PubMed ID: 6224858 [TBL] [Abstract][Full Text] [Related]
3. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology. Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399 [TBL] [Abstract][Full Text] [Related]
4. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani. Reiner NE J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis. Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606 [TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells. Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230 [TBL] [Abstract][Full Text] [Related]
8. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani. Holaday B; Sadick MD; Pearson RD J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649 [TBL] [Abstract][Full Text] [Related]
9. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Bhaumik SK; Naskar K; De T Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771 [TBL] [Abstract][Full Text] [Related]
10. The murine IL 2 receptor. III. Cellular requirements for the induction of IL 2 receptor expression on T cell subpopulations. Malek TR; Schmidt JA; Shevach EM J Immunol; 1985 Apr; 134(4):2405-13. PubMed ID: 3919092 [TBL] [Abstract][Full Text] [Related]
11. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421 [TBL] [Abstract][Full Text] [Related]
12. Activation of virus specific CTL clones: antigen-dependent regulation of interleukin 2 receptor expression. Andrew ME; Churilla AM; Malek TR; Braciale VL; Braciale TJ J Immunol; 1985 Feb; 134(2):920-5. PubMed ID: 3917480 [TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830 [TBL] [Abstract][Full Text] [Related]
14. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Melby PC; Yang J; Zhao W; Perez LE; Cheng J Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143 [TBL] [Abstract][Full Text] [Related]
15. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate. Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801 [TBL] [Abstract][Full Text] [Related]
16. Recognition of Leishmania donovani antigens by murine T lymphocyte lines and clones. Species cross-reactivity, functional correlates of cell-mediated immunity, and antigen characterization. Sheppard HW; Scott PA; Dwyer DM J Immunol; 1983 Sep; 131(3):1496-503. PubMed ID: 6193191 [TBL] [Abstract][Full Text] [Related]
17. Proliferation of T lymphocytes in response to interleukin 2 varies with their state of activation. Ashwell JD; Robb RJ; Malek TR J Immunol; 1986 Oct; 137(8):2572-8. PubMed ID: 3093577 [TBL] [Abstract][Full Text] [Related]
18. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis. Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098 [TBL] [Abstract][Full Text] [Related]
19. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses. Malek TR; Robb RJ; Shevach EM J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403 [TBL] [Abstract][Full Text] [Related]
20. Developmentally controlled expression of IL 2 receptors and of sensitivity to IL 2 in a subset of embryonic thymocytes. Hardt C; Diamantstein T; Wagner H J Immunol; 1985 Jun; 134(6):3891-4. PubMed ID: 3921613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]